The goal of this pilot randomized pilot controlled trial (RTC)is to collect acceptability and feasibility outcomes of a physiotherapy individualized program in women with levator injury that is intended to be used in a larger scale multicenter randomized controlled trial (RTC) in the future. The main questions it aims to answer are if a physiotherapy program in women with a levator injury: 1. Can improve the pelvic floor morphometry (PFM). 2. Can improve urogynecological symptoms 3. The effect of a physiotherapy program in the sexual function 4. The effect of a physiotherapy program in the patient's fear avoidance beliefs about physical activity and work Type of study: randomized pilot controlled trial (RTC) The design of this trial will be a pilot randomized controlled trial with 3 arms. Participants will be randomized in 2 arm of women with levator ani injury to either physiotherapy or standard care and an arm of woman without levator injury Researchers will compare the 3 groups to see if a physiotherapy program have benefits in morphometry of the pelvic floor, urogynecological symptoms, sexual function and to avoid fear avoidance beliefs about physical activity and work.
Age range
18 Years – 55 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Feasibility of the trial.
Timeframe: 4 months after delivery
Feasibility of the trial.
Timeframe: 6 months after delivery
Feasibility of the trial.
Timeframe: 12 months after delivery
Morphometry with ultrasound Area
Timeframe: 10-12 weeks after delivery
Morphometry with ultrasound Area
Timeframe: 12 months after delivery
Morphometry with ultrasound Levator urethra GAP (LUG)
Timeframe: 10-12 weeks after delivery
Morphometry with ultrasound Levator urethra GAP (LUG)
Timeframe: 12 months after delivery
Morphometry with ultrasound muscle thickness
Timeframe: 10-12 weeks after delivery
Morphometry with ultrasound muscle thickness
Timeframe: 12 months after delivery
Urogynecological symptoms.
Timeframe: 3 months after delivery
Urogynecological symptoms.
Timeframe: 6 months after delivery
Urogynecological symptoms.
Timeframe: 12 months after delivery
Urogynecological symptoms.
Timeframe: 3 months after delivery
Urogynecological symptoms.
Timeframe: 6 months after delivery
Urogynecological symptoms.
Timeframe: 12 months after delivery
Physics activity level.
Timeframe: 3 months after delivery
Physics activity level.
Timeframe: 6 months after delivery
Physics activity level.
Timeframe: 12 months after delivery
Sexual Function.
Timeframe: 3 months after delivery
Sexual Function.
Timeframe: 6 months after delivery
Sexual Function.
Timeframe: 12 months after delivery
Fear Avoidance Beliefs Questionnaire (Physical Activity/PA)
Timeframe: 3 months after delivery
Fear Avoidance Beliefs Questionnaire (Physical Activity/PA)
Timeframe: 6 months after delivery
Fear Avoidance Beliefs Questionnaire (Physical Activity/PA)
Timeframe: 12 months after delivery